Research Articles

  1. „Combination of the Amide-to-Triazole Substitution Strategy with Alternative Structural Modifications for the Metabolic Stabilization of Tumor-Targeting, Radiolabeled Peptides“ X. Guarrochena, M. Anderla, P. Salomon, I. V. J. Feiner, B. A. Nock, T. Maina, and T. L. Mindt, Journal of Peptide Sciences 2024, e3654. DOI: 10.1002/psc.3654
  2. “Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability” X.  Guarrochena, P. Kanellopoulos, A. Stingeder, L. M. Rečnik, I. V. J. Feiner, M. Brandt, W. Kandioller, T. Maina, B. A. Nock, and T. L. Mindt, Pharmaceutics 2024, 16, 392. DOI: https://doi.org/10.3390/pharmaceutics16030392
  3. “Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103” B. Happl, T. Balber, P. Heffeter, C. Denk, J. M. Welch, U. Köster, C. Alliot, A.-C. Bonraisin, M. Brandt, F. Haddad, J. H. Sterba, W. Kandioller, M. Mitterhauser, M. Hacker, B. K. Keppler, and T. L. Mindt, Dalton Transactions 2024, 53, 6031-6040. DOI: 10.1039/d4dt00118d
  4. “Quality Assurance Investigations and Impurity Characterization During Upscaling of [177Lu]Lu-PSMAI&T” S. Schmitl, J. Raitanen, S. Witoszynskyj, E.-M. Patronas, L. Nics, M. Ozenil, V. Weissenböck, T. L. Mindt, M. Hacker, W. Wadsak, M. R. Brandt, and M. Mitterhauser Molecules 2023, 28, 7696. DOI: https://doi.org/10.3390/molecules28237696
  5. “Synthesis and preclinical evaluation of radiolabeled [103Ru]BOLD-100” B. Happl, M. Brandt, T. Balber, K. Benčurová, Z. Talip, A. Voegele, P. Heffeter, W. Kandioller, N. P. van der Meulen, M. Mitterhauser, M. Hacker, B. K. Keppler, and T. L. Mindt, Pharmaceutics 2023, 15, 2626. https://doi.org/10.3390/pharmaceutics15112626
  6. “Automated Solid-Phase Synthesis of Metabolically Stabilized Triazolo-Peptidomimetics” X. Guarrochena, B. Kaudela, T. L. Mindt Journal of Peptide Science 2023 on-line. https://doi.org/10.1002/psc.3488
  7. Straightforward Synthesis of DFO* – an Octadentate Chelator for the Stable Complexation of Zirconium-89” X. Guarrochena, J. Kronberger, M. Tieber, P. Ciesielski, T. L. Mindt, I. V. J. Feiner, ChemMedChem 2023, 19, e202300495. DOI: https://doi.org/10.1002/cmdc.202300495
  8. “Towards Ruthenium(II)-Rhenium(I) Binuclear Complexes as Photosensitizers for Photo-dynamic Therapy” Y. Wang, P. S. Felder, P. Mesdom, O. Blacque, T. L. Mindt, K. Cariou, G. Gasser ChemBioChem 2023, accepted. DOI: https://doi.org/10.1002/cbic.202300467
  9. “Evaluation of a Macrocyclic Peptide as Potential PET Imaging Probe for PD-L1” N. Jouini, J. Cardinale, T. L. Mindt ChemMedChem 2022, 17, e202200091. DOI: https://doi.org/ 10.1002/cmdc.202200091
  10. “Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[11C]Me-NB1” L. Rischka, V. Pichler, C. Vraka, I. Rausch, D. Winkler, L. Nics, S. Rasul, L. R. Silberbauer, M. Murgaš, M. B. Reed, G. M. Godbersen, J. Unterholzner, P. Handschuh, G. Gryglewski, T. Mindt, M. Mitterhauser, A. Hahn, S. M. Ametamey, W. Wadsak, R. Lanzenberger, M. Hacker European Journal of Nuclear Medicine and Molecular Imaging 2022, 12-53. https://doi.org/10.1186/s13550-022-00925-8
  11. “First-in-Human Brain Imaging of the GluN2B-Containing N-Methyl-D-Aspartate Receptor with (R)-11C-Me-NB1 PET” L. Rischka, C. Vraka, V. Pichler, S. Rasul, L. Nics, G. Gryglewski, P. Handschuh, M. Murgas, G. N. Godbersen, L. Silberbauer, M. Unterholzner, C. Wotawa, A. Haider, H. Ahmed, R. Schibli, T. L. Mindt, M. Mitterhauser, W. Wadsak, A. Hahn, R. Lanzenberger, M. Hacker, S. M. Ametamey Journal of Nuclear Medicine 2022, 63, 936-941. DOI: https://doi.org/10.2967/jnumed.121.262427
  12. “Unexpected transformation of n.c.a. [111In]InCl3 in stock solutions into an unreactive 111In-species” C. Giammei, N. Jouini, M. R. Brandt, S. Frey, T. L. Mindt, J. Cardinale Applied Radiation and Isotopes 2021, 180, 110037-110040. DOI: doi.org/10.1016/j.apradiso.2021.110037
  13. “Development and in vitro evaluation of new bifunctional 89Zr-chelators based on the 6-amino-1,4-diazepane scaffold for immuno-PET applications” B. Klasen, D. Lemcke, T. L. Mindt, G. Gasser, F. Rösch Nuclear Medicine and Biology 2021, 102-103, 12-23. DOI: https://doi.org/10.1016/j.nucmedbio.2021.06.007 
  14. “Improved Tumor-Targeting with Peptidomimetic Analogs of Minigastrin 177Lu-PP-F11N” N. M. Grob, R. Schibli, M. Béhé, T. L. Mindt Cancers 2021, 13, 2629. DOI: doi.org/10.3390/cancers13112629
  15.  “1,5-Disubstituted 1,2,3-Triazoles as Amide Bond Isosteres Yield Novel Tumor-Targeting Minigastrin Analogs” N. M. Grob, R. Schibli, M. Behe, I. E. Valverde, T. L. Mindt Medicinal Chemistry Letters 2021, 12, 585-592. DOI: doi.org/10.1021/acsmedchemlett.0c00636
  16. “Single Peptide Backbone Surrogate Mutations to Regulate GPCR Subtype Selectivity” E. I. Vrettos, I. E. Valverde, A. Mascarin, P. N. Pallier, M. Fragai, G. Parigi, B. Hirmiz, N. Bekas, N. M. Grob, E. Stylos, M. Del Borgo, M.-I. Aguilar, F. Magnani, N. Syed, T. Crook, E. Waqif, E. Ghazaly, R. E. Widdop, C. Luchinat, A. T. Michael-Titus, T. L. Mindt, A. G. Tzakos Chemistry – A European Journal 2020, 26, 10690-10694 (highlighted as cover page illustration, shared corresponding authorship T. L. M. and A. G. T.). DOI: 10.1002/chem.202000924
  17. “Head to Head Comparison of the Next Generation Chelators DFO*-NCS and DFOSquaramide: Selection of the Best Candidate for Clinical 89Zr-Immuno-PET” M. Chomet, M. Schreurs, M. J. Bolijn, M. Verlaan, W. Beaino, K. Brown, A. J. Poot, A. D. Windhorst, H. Gill, J. Marik, S. Williams, S. E. Rudd, P. Donnelly, J. Cowell, G. Gasser, T. L. Mindt, G.A.M.S van Dongen, D. J. Vugts European Journal of Nuclear Medicine and Molecular Imaging 2020, 48, 694-707. DOI: 10.1007/s00259-020-05002-7
  18.  “Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of 99mTc-Tricarbonyl-Based Radiopharmaceuticals” C. Giammei, T. Balber, K. Bencurova, J. Cardinale, N. Berroterán-Infante, M. Brandt, N. Jouini, M. Hacker, M. Mitterhauser and T. L. Mindt Molecules 2020, 25, 2680-2694. DOI: 10.3390/molecules25112680
  19.  “DFO* and oxoDFO*: Optimized Chelators for 89Zr-ImmunoPET Applications” M. Brandt, J. Cowell, M. Briand, G. Gasser, T. L. Mindt Journal of Biological Inorganic Chemistry 2020, 25, 789-796. DOI: 10.1007/s00775-020-01800-4
  20. “Design of Radiolabeled Minigastrin Analogs by Multiple Amide-to-Triazole Substitutions for Enhanced Tumor Targeting” N. M. Grob, S. Schmid, R. Schibli, M. Béhé, T. L. Mindt Journal of Medicinal Chemistry 2020, 63, 4496-4505. DOI: 10.1021/acs.jmedchem.9b01937
  21. “Triazolo-Peptidomimetics: Novel Radiolabeled Minigastrin Analogs for Improved Tumor Targeting” N. M. Grob, D. Häussinger, X. Deupi, R. Schibli, M. Béhé, T. L. Mindt Journal of Medicinal Chemistry 2020, 63, 4484-4495. DOI: 10.1021/acs.jmedchem.9b01936
  22. “Comparison of Desferrioxamine and NODAGA for the Gallium-68 Labeling of Exendin-4” S. A. M. Kaeppeli, R. Schibli, T. L. Mindt, M. Behe European Journal of Nuclear Medicine and Molecular Imaging – Radiopharmacy and Chemistry 2019, 4, 9. DOI: 10.1186/s41181-019-0060-9
  23. “A Solid Phase-Assisted Approach for the Facile Synthesis of a Highly Water Soluble Octadentate Zirconium-89 Chelator for Radiopharmaceutical Development” M. Briand, M.  Aulsebrook, T. L. Mindt, G. Gasser, Dalton Transactions 2017, 46, 6387-16389 (shared corresponding authorship T. L. M. and G. G.). DOI: 10.1039/C7DT03639F
  24. “Amide-to-Triazole Switch vs. In Vivo NEP-Inhibition Approaches to Promote Radiopeptide Targeting of GRPR-Positive Tumors” T. Maina, A. Kaloudi, I. E. Valverde, T. L. Mindt, B. A. Nock Nuclear Medicine and Biology 2017, 52, 57-62 (shared corresponding authorship B. A. N. and T. L. M.). DOI: 10.1016/j.nucmedbio.2017.06.001
  25. “Methoxinine – An Alternative Stable Amino Acid Substitute for Oxidation-Sensitive Methionine in Radiolabeled Peptide Conjugates” N. M. Grob, M. Behe, E. von Guggenberg, R. Schibli, T. L. Mindt Journal of Peptide Science 2017, 23, 38-44. DOI: 10.1002/psc.2948
  26. “Glycated 99mTc-Tricarbonyl Labelled Peptide Conjugates for Tumour Targeting by Click-to-Chelate” K. Römhild, C. A. Fischer, T. L. Mindt ChemMedChem 2017, 12, 66-74. DOI: 10.1002/cmdc.201600485
  27.  “Comparison of the Octadentate Bifunctional Chelator DFO*-pPhe-NCS and the Clinically Used Hexadentate Bifunctional Chelator DFO-pPhe-NCS for 89Zr-Immuno-PET” D. J. Vugts, C. Klaver, C. Sewing, A. J. Poot, K. Adamzek, S. Huegli, C. Mari, I. E. Valverde, G. Gasser, T. L. Mindt, G.A.M.S. van Dongen European Journal of Nuclear Medicine and Molecular Imaging 2017, 44, 286-295 (shared corresponding authorship D. J. V., G. G., and T. L. M.). DOI: 10.1007/s00259-016-3499-x
    (awarded with the Best Article Award of the Journal of Nuclear Medicine and Molecular Imaging in 2019 – Springer)
  28.  “Radiolabeled Analogs of Neurotensin (8-13) Containing Multiple 1,2,3-Triazoles as Stable Amide Bond Mimics in the Backbone” A. Mascarin, I. E. Valverde, T. L. Mindt Medicinal Chemical Communications 2016, 7, 1640-1646. DOI: 10.1039/c6md00208k
  29.  “Novel Chemoselective 18F-Radiolabeling of Thiol-Containing Biomolecules Under Mild Aqueous Conditions” A. Chiotellis, F. Sladojevich, L. Mu, A. Müller Herde, I. E. Valverde, V. Tolmachev, R. Schibli, S. M. Ametamey, T. L. Mindt Chemical Communications 2016, 52, 6083-6086 DOI: 10.1039/c6cc01982j (highlighted in the section Swiss Science Concentrates of Chimia, the journal of the Swiss Chemical Society (Chimia 2016, 70, 455)).
  30.  “Towards the Optimization of Bombesin-Based Radiotracers for Tumor Targeting” I. E. Valverde. S. Vomstein, T. L. Mindt Journal of Medicinal Chemistry 2016, 59, 3867-3877. DOI: 10.1021/acs.jmedchem.6b00025
  31. “Structure-Activity Relationship Studies of Amino Acid Substitutions in Radiolabeled Neurotensin Conjugates” A. Mascarin, I. E. Valverde, T. L. Mindt ChemMedChem 2016, 11, 102 –107 (highlighted as cover page illustration). DOI: 10.1002/cmdc.201500468
  32. “1,2,3-Triazole Stabilized Neurotensin-Based Radiopeptidomimetics for Improved Tumor Targeting” A. Mascarin, I. E. Valverde, S. Vomstein, T. L. Mindt Bioconjugate Chemistry 2015; 26, 2143–2152. DOI: 10.1021/acs.bioconjchem.5b00444
  33. “Probing the Backbone Function of a Bombesin-Based Radiotracer by an Amide-to-Triazole Substitution Strategy” I. E. Valverde, S. Vomstein, T. L. Mindt Journal of Medicinal Chemistry 2015, 58, 7475–7484. DOI: 10.1021/acs.jmedchem.5b00994
  34. “Development of Gallium-68 and Zirconium-89 Labelled Exendin-4 for the Imaging of Insulinomas by PET” A. Bauman, I. E. Valverde, C. A. Fischer, S. Vomstein, T. L. Mindt Journal of Nuclear Medicine and Molecular Imaging 2015, 56, 1569-1574. DOI: 10.2967/jnumed.115.159186
  35.  “Regioselective 1,2-Addition of Organometallic Reagents to Unprotected Juglones” K. A. Parker, T. L. Mindt Tetrahedron Letters 2015, 56, 3500-3502. DOI: 10.1016/j.tetlet.2014.12.108
  36.  “An Octadentate Bifunctional Chelating Agent for the Development of Stable Zirconium-89 Based Molecular Imaging Probes” M. Patra, A. Bauman, C. Mari,C. A. Fischer, O. Blacque,D. Häussinger, G. Gasser, T. L. Mindt Chemical Communications 2014, 50, 11523-11525 DOI: 10.1039/c4cc05558f
    (highlighted in the section Swiss Science Concentrates of Chimia, the journal of the Swiss Chemical Society (Chimia 2014, 68, 820)).
  37. “A Bombesin-Shepherdin Radioconjugate Designed for Combined Extra- and Intracellular Targeting” C. A. Fischer, S. Vomstein, T. L. Mindt Pharmaceuticals 2014, 7, 662-675. DOI: 10.3390/ph7060662
  38. “Expression of Different Neurokinin Type 1-Receptor Isoforms in Glioblastoma Multiforme – Implications for Targeted Therapy” D. Cordier, A. Gerber, C. Kluba, A. Bauman, G. Hutter, T. L. Mindt, L. Mariani Cancer Biotherapy & Radiopharmaceuticals 2014, 29, 221-226 (shared corresponding authorship  T. L. M. and D. C.). DOI: 10.1089/cbr.2013.1588
  39.  “Radiolabeled Antagonistic Bombesin Peptidomimetics for Tumor Targeting” I. E. Valverde, E. Huxol, T. L. Mindt Journal of Labeled Compounds and Radiopharmaceuticals 2014, 57, 275–278. DOI: doi.org/10.1002/jlcr.3162
  40. “1,2,3-Triazoles as Amide Bond Mimics: Triazole Scan Yields Protease-Resistant Peptidomimetics for Tumor Targeting” I. E. Valverde, A. Bauman,  C. A. Kluba, S. Vomstein, M. Walter, T. L. Mindt Angewandte Chemie International Edition, 2013, 52, 8957-8960 (highlighted in the section Swiss Science Concentrates of Chimia, the journal of the Swiss Chemical Society (Chimia 2013, 67(10), 738), and in q&more (2013, 2, 56); highlighted on-line at bionity.com, schattenblick.de, news.doccheck.com, and ingentaconnect.com). DOI: 10.1002/anie.201303108
  41. “1,2,3-Triazole als Mimetika der Amid-Bindung: Ein Triazol-Scan führt zu Protease-resistenten Peptidmimetika für das Tumor-Targeting“ I. E. Valverde, A. Bauman,  C. A. Kluba, S. Vomstein, M. Walter, T. L. Mindt Angewandte Chemie 2013, 125, 9126-9129 (in German). DOI: 10.1002/ange.201303108
  42.  “Effect of a Spacer Moiety on Radiometal Labelled Neurotensin Derivatives” A. Mascarin, I. E. Valverde, T. L. Mindt Radiochimica Acta 2013, 11, 733-738. DOI: 10.1524/ract.2013.2090
  43. “Dual-Targeting Conjugates Designed to Improve the Efficacy of Radiolabeled Peptides” C. A. Kluba, A. Bauman, I. E. Valverde, S. Vomstein, T. L. Mindt Organic & Biomolecular Chemistry 2012, 10, 7594-7602. DOI: 10.1039/c2ob26127h
  44. “Synthesis, Gallium-68 Labeling and Biological Evaluation of DOTA-, NODAGA- and Desferrioxamine-modified Nanoparticles” Q.K.T. Ng, T. Segura, A. Ben-Shlomo, T. Krause, T. L. Mindt, M. A. Walter Journal of Nano Research 2012, 20, 21-31. DOI: 10.4028/www.scientific.net/JNanoR.20.21
  45. “Fluorescent Gallium and Indium Bis(thiosemicarbazonates) and Their Radiolabelled Analogues: Design, Synthesis and Cellular Confocal Fluorescence Imaging Investigations” R. L. Arrowsmith, P. A. Waghorn, A. Bauman, S. K. Brayshaw, Z. Hu, M. W. Jones, G. Kociok-Kohn, T. L. Mindt, R. M. Tyrrell, S. W. Botchway, J. R. Dilworth, S. I. Pascu Dalton Transactions 2011, 40, 6238-6252. DOI: 10.1039/c1dt10126a
  46. “Convergent Synthesis of 2H-Chromenes – a Formal [3+3] Cycloaddition by a One-pot, Three Step Cascade” K. A. Parker, T. L. Mindt Tetrahedron 2011, 67, 9779-9786. DOI: 10.1016/j.tet.2011.09.068
  47. “Effect of Amino Acid Infusion on Potassium Serum Levels in Neuroendocrine Tumor Patients Treated with Peptide-Receptor Radionuclide Therapy“ G. Giovacchini,  G. Nicolas, T. L. Mindt, F. Forrer European Journal of Nuclear Medicine and Molecular Imaging 2011, 38, 1675-1682. DOI: 10.1007/s00259-011-1826-9
  48. „Imaging of Activated Macrophages in Experimental Osteoarthritis Using Folate Targeted Animal SPECT/CT“ T. M. Piscaer, C. Müller, T. L. Mindt, E. Lubberts,J. A. N. Verhaar,E. P. Krenning, R. Schibli,M. De Jong, H. Weinans Arthritis & Rheumatism 2011, 63, 1898–1907. DOI: 10.1002/art.30363
  49. “Molecular Assembly of Multifunctional Tc-99m Radiopharmaceuticals using “Clickable” Amino Acid Derivatives“ T. L. Mindt, H. Struthers, B. Spingler, L. Brans, D. Tourwe, E. Garcia-Garayoa, R. Schibli ChemMedChem 2010, 5, 2026-2038. (highlighted as cover page illustration; among the most accessed articles between 09/2010-08/2011). DOI: 10.1002/cmdc.201000342
  50. “A Click Chemistry Approach to the Efficient Synthesis of Multiple Imaging Probes Derived from a Single Precursor” T. L. Mindt, C. Müller, F. Stuker, J.-F. Salazar, A. Hohn, T. Mueggler, M. Rudin, R. Schibli Bioconjugate Chemistry 2009, 20, 1940-1949. DOI: 10.1021/bc900276b
  51. “A Click Approach to Structurally Diverse Conjugates Containing a Central Di-1,2,3-Triazole Metal Chelate” T. L. Mindt, C. Schweinsberg, L. Brans, A. Hagenbach, U. Abram, D. Tourwé, E. Garcia-Garayoa,R. Schibli ChemMedChem 2009, 4, 529. (among the top 10 most frequently cited articles of ChemMedChem 2009). DOI: 10.1002/cmdc.200800418
  52. “Evaluation of a Novel Radiofolate in Tumor-Bearing Mice – Promising Prospects for Folate-Based Radionuclide Therapy” C. Müller, T. L. Mindt, M. de Jong, R. Schibli European Journal of Nuclear Medicine and Molecular Imaging 2009,36, 938. DOI: 10.1007/s00259-008-1058-9
  53. “Click Chemistry Radiosynthesis and Preclinical Evaluation of a New 18F-Labelled Folic Acid Derivative” T. L. Ross, M. Honer, P. Y. H. Lam, T. L. Mindt, V. Groehn, R. Schibli, P. A. Schubiger, S. M. Ametamey Bioconjugate Chemistry 2008, 19, 2462. DOI: 10.1021/bc800356r
  54. “Click-to-Chelate: In Vitro and In Vivo Comparison of a 99mTc(CO)3-Labeled N(t)-Histidine Folate Derivative with Its Isostructural, Clicked 1,2,3-Triazole Analogue” T. L. Mindt, C. Müller, M. Melis, M. de Jong, R. Schibli Bioconjugate Chemistry 2008, 19, 1689. (highlighted as cover page illustration; highlighted on-line in Vertical News Chemicals&Chemistry). DOI: 10.1021/bc800183r
  55. Click-to-Chelate: Design and Incorporation of Triazole Containing Metal Chelating Systems into Biomolecules of Diagnostic and Therapeutic Interest”; H. Struthers, B. Spingler, T. L. Mindt, R. Schibli Chemistry – A European Journal 2008, 14, 6173. DOI: 10.1002/chem.200702024
  56. “Modification of Different IgG1 Antibodies via Glutamine and Lysine using Bacterial and Human Tissue Transglutaminase” T. L. Mindt, V. Jungi, S. Wyss, A. Friedli, G. Pla, I. Novak-Hofer, J. Grünberg, R. Schibli Bioconjugate Chemistry 2008, 19, 271. DOI: 10.1021/bc700306n
  57. “Cu(I)-Catalyzed Intramolecular Cyclization of Alkynoic Acids in Aqueous Media – a Click Side Reaction”; T. L. Mindt, R. Schibli The Journal of Organic Chemistry 2007, 72, 10247. DOI: 10.1021/jo702030e
  58. “Click to Chelate: Synthesis and Installation of Metal Chelates into Biomolecules in a Single Step” T. L. Mindt, H. Struthers, L. Brans, T. Anguelov, C. Schweinsberg, V. Maes, D. Tourwé, and R. Schibli Journal of the American Chemical Society 2006, 128, 15096. (highlighted on-line in Noteworthy Chemistry of the American Chemical Society; highlighted on-line by the Faculty 1000 Biology Reports). DOI: 10.1021/ja066779f
  59. “TESOTf-Induced Rearrangement of Quinols. Efficient Construction of the Fully functionalized Carbon Skeleton of the Griseusins by a Divergent-Reconvergent Approach”; K. A. Parker, T. L. Mindt, Y.-H. Koh Organic Letters 2006,8, 1759. DOI: 10.1021/ol060206q
  60. “Heterocycle Annulation of Enolizable Vinyl Quinone Imides. Dihydroquinolines and Quinolines from Thermal 6π-Electrocyclizations and Indoles from Photochemical Cyclizations”; K. A. Parker, T. L. Mindt Organic Letters 2002, 4 (24), 4265. DOI: 10.1021/ol026849x
  61. “Electrocyclic Ring Closure of the Enols of Vinyl Quinones. A 2H-Chromene Synthesis”; K. A. Parker, T. L. Mindt Organic Letters 2001, 3 (24), 3875. DOI: 10.1021/ol0167199
  62. “Synthesis and Evaluation of Enantiomeric Purity of Protected a-Amino and Peptide Aldehydes”; T. Mindt, U. Michel, F. Dick Helvetica Chimica Acta 1999, 82, 1960. DOI: 10.1021/ma00113a003
  63. “a-Sulfinyl Substituted Radicals; II. Stereoselective Inter- and Intramolecular Addition Reactions of Acyclic a‑Sulfinyl Radicals”; A. De Mesmaeker, A. Waldner, P. Hoffmann, T. Mindt Synlett 1993, 11, 871. DOI: 10.1055/s-1993-22638
  64. “a-Sulfinyl Substituted Radicals; I. Stereoselective Radical Addition Reactions of Cyclic a-Sulfinyl Radicals”; A. Waldner, A. De Mesmaeker, P. Hoffmann, T. Mindt, T. Winkler Synlett 1991, 2, 101. DOI: 10.1055/s-1991-20642
  65. “Stereoselectiv Carbon-Carbon Bond Formation in Carbohydrates by Radical Cyclization Reactions”; A. De Mesmaeker, A. Waldner, P. Hoffmann, T. Mindt, P. Hug, T. Winkler Synlett 1990, 11, 687. DOI: 10.1055/s-1990-21212